Gut Microbiota: Novel Therapeutic Target of Ginsenosides for the Treatment of Obesity and Its Complications.

Zhuang, Tongxi; Li, Wei; Yang, Li; Wang, Zhengtao; Ding, Lili; Zhou, Mingmei

Zhuang, Tongxi; Li, Wei; Yang, Li; Wang, Zhengtao; Ding, Lili; Zhou, Mingmei.

Afiliación

Zhuang T; Shanghai Key Laboratory of Complex Prescriptions and MOE Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Li W; Center for Chinese Medicine Therapy and Systems Biology, Institute for Interdisciplinary Medicine Sciences, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Yang L; Shanghai Key Laboratory of Complex Prescriptions and MOE Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Wang Z; Shanghai R&D Center for Standardization of Traditional Chinese Medicines, Shanghai, China.
Ding L; Shanghai Key Laboratory of Complex Prescriptions and MOE Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Zhou M; Shanghai R&D Center for Standardization of Traditional Chinese Medicines, Shanghai, China.

Front Pharmacol ; 12: 731288, 2021.

Article en En | MEDLINE | ID: mdl-34512356

Palabras clave

ginsenosides; gut microbiota; mechanism; obesity; target

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google